Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln
26/08/2026 07:11
BRIEF-BioArctic Q2 Net Sales Down At SEK 247.5 Mln Aug 26 (Reuters) - BioArctic AB (publ) BIOAb.ST:
Q2 NET SALES SEK 247.5 MILLION INCLUDING SEK 179.4 MILLION LEQEMBI ROYALTIES
Q2 OPERATING LOSS SEK 6.5 MILLION
Source text: ID:nWkr44M8fY
Further company coverage: [BIOAb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln